ABL Organization

Advanced Bioscience Laboratories (ABL) is a premier contract development and manufacturing organization (CDMO) and contract research organization (CRO) dedicated to the development of vaccines and immunotherapeutics. With over 60 years of experience, the company provides end-to-end services including preclinical research, process development, and GMP manufacturing for viral vectors, recombinant proteins, and other biologics. ABL is a long-standing partner to the U.S. government, particularly the National Institutes of Health (NIH), supporting critical research in infectious diseases such as HIV, COVID-19, and Ebola. Operating state-of-the-art facilities in the United States and Europe, ABL offers specialized expertise in both upstream and downstream processing as well as fill-and-finish services. As a subsidiary of Institut Mérieux, ABL leverages a global network to accelerate the transition of innovative biological candidates from the laboratory to clinical application.